Cardiovascular surgical experiences of IVC tumor and thrombus: Operative strategies Based on 51 consecutive patients
Asian Cardiovascular and Thoracic Annals · 2023
DOI: 10.1177/02184923231177658 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asian Cardiovascular and Thoracic Annals, 2023. Verfasst von Mehrzad Rahmanian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Thrombosis, Venous Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
Background
The only beneficial treatment option for the management of inferior vena cava (IVC) tumor thrombus is complete tumor removal. The aim of this study was to report our experience in surgical and clinical outcomes in patients with tumor thrombosis in IVC.
Methods
A retrospective chart review of patients who underwent surgical resection of IVC tumor at our institution over the past 10 years was performed. The patients were identified using a prospectively maintained database.
Results
We identified 51 patients, the mean age was 53.4 ± 16.8 years, and 25.4% were female. They were divided into three groups based on tumor thrombosis level. Twenty patients (39.2%) required sternotomy, and cardiopulmonary bypass (CPB) was used in 19 (37.2%) patients, and 2 (3.9%) cases underwent coronary artery bypass graft. The perioperative complications were severe bleeding (3 patients), pulmonary embolism (2 patients), and duodenal perforation (1 patient). Three (5.8%) in-hospital deaths occurred, and all were due to severe abdominal bleeding. After a mean follow-up time of 46.5 ± 42.0 months, 29 (56.9%) patients were alive. The mean survival time was 75.2 ± 8.4 months. In multivariate analysis, higher age ( p = 0.033) and male gender ( p = 0.033) proved to be independent prognostic factors.
Conclusions
Tumor thrombus extending to the IVC is a rare and challenging event. Although using CPB may be safe and result in long-term survival with acceptable function, excessive bleeding during surgery may limit the use of this method.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran.
- Department of Cardiology, Tehran University of Medical Science, Tehran, Iran.
- Uro-Oncology Research Center, Tehran University of Medical Science, Tehran, Iran.
- Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran.
- Department of Surgery, Shiraz University of Medical Sciences, Shiraz, Iran.
- Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.
ORCID-Profile: Farnoosh Larti, Hamidreza Malekhosseini
Zitieren
APA
Rahmanian, M., Badkoubeh, R. S., Rasouli, S. J., Nowroozi, M. R., Saberi, K., Salehi, M., Larti, F., Tajaddini, A., Fatemian, H., Rad, M. R., Dabaghi, G. G., & Malekhosseini, H. (2023). Cardiovascular surgical experiences of IVC tumor and thrombus: Operative strategies Based on 51 consecutive patients. Asian Cardiovascular and Thoracic Annals. https://doi.org/10.1177/02184923231177658
Vancouver
Rahmanian M, Badkoubeh RS, Rasouli SJ, Nowroozi MR, Saberi K, Salehi M, et al. Cardiovascular surgical experiences of IVC tumor and thrombus: Operative strategies Based on 51 consecutive patients. Asian Cardiovascular and Thoracic Annals. 2023. doi:10.1177/02184923231177658
BibTeX
@article{Rahmanian2023,
author = {Rahmanian, Mehrzad and Badkoubeh, Roya Sattarzadeh and Rasouli, Seyed Jaber and Nowroozi, Mohammad Reza and Saberi, Kianoush and Salehi, Mehrdad and Larti, Farnoosh and Tajaddini, Ali and Fatemian, Hossein and Rad, Mehrdad Rabiee and Dabaghi, Ghazal Ghasempour and Malekhosseini, Hamidreza},
title = {Cardiovascular surgical experiences of IVC tumor and thrombus: Operative strategies Based on 51 consecutive patients},
journal = {Asian Cardiovascular and Thoracic Annals},
year = {2023},
doi = {10.1177/02184923231177658}
}
EUVIMED